AYALA PHARMACEUTICALS INC (AYLA) Forecast, Price Target & Analyst Ratings

NASDAQ:AYLAUS05465V1089

Current stock price

0.5036 USD
+0.03 (+5.84%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AYALA PHARMACEUTICALS INC (AYLA).

Forecast Snapshot

Consensus Price Target

Price Target
$12.24
+ 2,330.50% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 27, 2023
Period
Q4 / 2022
EPS Estimate
-$0.74
Revenue Estimate
408K

ChartMill Buy Consensus

Rating
77.78%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.24
Upside
+ 2,330.50%
From current price of $0.50 to mean target of $12.24, Based on 9 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60

Price Target Revisions

1 Month
2.86%
3 Months
6.33%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for AYLA. The average price target is 12.24 USD. This implies a price increase of 2330.5% is expected in the next year compared to the current price of 0.5036.
The average price target has been revised upward by 6.33% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

AYLA Current Analyst RatingAYLA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

AYLA Historical Analyst RatingsAYLA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
77.78%
AYLA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about AYLA.
In the last month the buy percentage rose by 28 points. So the trust of analysts is improving.
AYLA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-10-31OppenheimerDowngrade Outperform -> Perform
2022-10-20Roth CapitalDowngrade Buy -> Sell
2022-09-20Noble Capital MarketsDowngrade Outperform -> Market Perform
2022-08-16HC Wainwright & Co.Maintains Buy
2021-12-20Maxim GroupInitiate Buy
2021-12-20HC Wainwright & Co.Initiate Buy
2021-11-30JefferiesUpgrade Hold -> Buy
2021-08-17OppenheimerMaintains Outperform
2021-07-13Ladenburg ThalmannInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 27, 2023
Period
Q4 / 2022
EPS Estimate
-$0.74
Revenue Estimate
408K
Revenue Q2Q
-64.40%
EPS Q2Q
-12.82%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-42.86%
EPS (1 Month)
0.00%
EPS (3 Months)
-43.61%

Next Earnings Summary

AYLA is expected to report earnings on 3/27/2023. The consensus EPS estimate for the next earnings is -0.74 USD and the consensus revenue estimate is 408.00K USD.
The next earnings revenue estimate has been revised downward by 42.86% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2022 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
AYLA revenue by date.AYLA revenue by date.
2.33M3.71M
59.23%
3.506M
-5.50%
2.04M
-41.81%
2.346M
15.00%
N/A
EBITDA
YoY % growth
AYLA ebitda by date.AYLA ebitda by date.
-17.56M
-95.33%
-29.6M
-68.56%
-39.05M
-31.93%
N/AN/AN/A
EBIT
YoY % growth
AYLA ebit by date.AYLA ebit by date.
-17.71M
-95.91%
-29.78M
-68.15%
-39.218M
-31.69%
-38.25M
2.47%
-33.456M
12.53%
N/A
Operating Margin
AYLA operating margin by date.AYLA operating margin by date.
-760.09%-802.70%-1,118.60%-1,875.00%-1,426.09%N/A
EPS
YoY % growth
AYLA eps by date.AYLA eps by date.
N/A-3.38-2.83
16.27%
-2.73
3.59%
-2.34
14.21%
-3.57
-52.64%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22
EPS
Q2Q % growth
-0.74
-12.82%
Revenue
Q2Q % growth
408K
-64.40%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-12.342M
-26.36%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AYLA Yearly Revenue VS EstimatesAYLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 1M 2M 3M
AYLA Yearly EPS VS EstimatesAYLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-8.08%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

AYALA PHARMACEUTICALS INC / AYLA Forecast FAQ

What do analysts expect the price target to be for AYALA PHARMACEUTICALS INC (AYLA)?

9 analysts have analysed AYLA and the average price target is 12.24 USD. This implies a price increase of 2330.5% is expected in the next year compared to the current price of 0.5036.

When does AYALA PHARMACEUTICALS INC (AYLA) report earnings?

AYALA PHARMACEUTICALS INC (AYLA) will report earnings on 2023-03-27.

What are the consensus estimates for AYLA stock next earnings?

The consensus EPS estimate for the next earnings of AYALA PHARMACEUTICALS INC (AYLA) is -0.74 USD and the consensus revenue estimate is 408.00K USD.